BioCentury | Jun 16, 2008
Company News

Amnestix Inc., Sygnis Pharma deal

...disease and other neurological diseases. TGEN is currently working on identifying compounds that interact with protein kinase M zeta...
BioCentury | Jun 9, 2008
Strategy

Adding shots on goal

...initial focus will be on developing compounds that interact with the protein kinase C isoform, protein kinase M zeta...
Items per page:
1 - 2 of 2